» Articles » PMID: 33298439

Cryo-shocked Cancer Cells for Targeted Drug Delivery and Vaccination

Overview
Journal Sci Adv
Specialties Biology
Science
Date 2020 Dec 10
PMID 33298439
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Live cells have been vastly engineered into drug delivery vehicles to leverage their targeting capability and cargo release behavior. Here, we describe a simple method to obtain therapeutics-containing "dead cells" by shocking live cancer cells in liquid nitrogen to eliminate pathogenicity while preserving their major structure and chemotaxis toward the lesion site. In an acute myeloid leukemia (AML) mouse model, we demonstrated that the liquid nitrogen-treated AML cells (LNT cells) can augment targeted delivery of doxorubicin (DOX) toward the bone marrow. Moreover, LNT cells serve as a cancer vaccine and promote antitumor immune responses that prolong the survival of tumor-bearing mice. Preimmunization with LNT cells along with an adjuvant also protected healthy mice from AML cell challenge.

Citing Articles

Immunogenic dying cells elicit potent anti-tumor T cell immunity against lung metastasis and tumorigenesis.

Hu M, Meng X, Wang T, Wang Y, Chen X, Xu D J Cancer Res Clin Oncol. 2025; 151(1):38.

PMID: 39825073 PMC: 11741992. DOI: 10.1007/s00432-025-06087-z.


Homologous-adhering/targeting cell membrane- and cell-mediated delivery systems: a cancer-catch-cancer strategy in cancer therapy.

Liu C, Gao J, Cheng Y, Zhang S, Fu C Regen Biomater. 2025; 12:rbae135.

PMID: 39811105 PMC: 11729729. DOI: 10.1093/rb/rbae135.


Cryoshocked Adipocytes Mediated Dual-Modal Strategy Combining Photodynamic Therapy and Triptolide Palmitate for Pulmonary Metastatic Melanoma Treatment.

Li A, Qi F, Zeng Y, Liu R, Cai H, He M Adv Sci (Weinh). 2025; 12(9):e2414307.

PMID: 39804941 PMC: 11884613. DOI: 10.1002/advs.202414307.


Emerging advances in drug delivery systems (DDSs) for optimizing cancer complications.

Li K, Guo B, Gu J, Ta N, Gu J, Yu H Mater Today Bio. 2025; 30:101375.

PMID: 39759851 PMC: 11699619. DOI: 10.1016/j.mtbio.2024.101375.


A cryo-shocked M2 macrophages based treatment strategy promoting repair of spinal cord injury via immunomodulation and axonal regeneration effects.

Lu E, Zhou K, Miao J, Zhu Y, Tang J, Du S J Nanobiotechnology. 2025; 23(1):8.

PMID: 39757205 PMC: 11702283. DOI: 10.1186/s12951-024-03018-x.


References
1.
Wang Q, Cheng H, Peng H, Zhou H, Li P, Langer R . Non-genetic engineering of cells for drug delivery and cell-based therapy. Adv Drug Deliv Rev. 2014; 91:125-40. DOI: 10.1016/j.addr.2014.12.003. View

2.
Prise K, Schettino G, Folkard M, Held K . New insights on cell death from radiation exposure. Lancet Oncol. 2005; 6(7):520-8. DOI: 10.1016/S1470-2045(05)70246-1. View

3.
Copelan E . Hematopoietic stem-cell transplantation. N Engl J Med. 2006; 354(17):1813-26. DOI: 10.1056/NEJMra052638. View

4.
Konopleva M, Jordan C . Leukemia stem cells and microenvironment: biology and therapeutic targeting. J Clin Oncol. 2011; 29(5):591-9. PMC: 4874213. DOI: 10.1200/JCO.2010.31.0904. View

5.
Bakker E, Qattan M, Mutti L, Demonacos C, Krstic-Demonacos M . The role of microenvironment and immunity in drug response in leukemia. Biochim Biophys Acta. 2015; 1863(3):414-426. DOI: 10.1016/j.bbamcr.2015.08.003. View